Form 4: CME Group Director William R. Shepard Reports Significant Stock Acquisitions
Insider Trading Report
CME Group Director William R. Shepard has reported the acquisition of additional Class A common stock through a stock plan grant and dividend reinvestment, increasing his beneficial ownership.
Summary
- William R. Shepard, a Director of CME Group Inc. (CME), reported multiple acquisitions of Class A Common Stock on June 25, 2025.
- He acquired 879 shares at $273.03 per share, granted pursuant to the CME Group Director Stock Plan. These shares are beneficially owned indirectly by a Trust.
- An additional 256.097 shares were acquired at $270.53 per share through a dividend reinvestment plan, also beneficially owned indirectly by a Trust.
- Furthermore, 11.29 shares were acquired directly at $270.53 per share via a dividend reinvestment plan.
- Following these transactions, Mr. Shepard's beneficial ownership includes 258,196.087 shares indirectly by Trust and 2,454.76 shares directly.
Sentiment
Score: 8
Explanation: The acquisition of shares by a director, both through a stock plan and dividend reinvestment, indicates strong insider confidence and alignment with shareholder interests, which is a positive signal for investors.
Positives
- Increased beneficial ownership by a director, signaling confidence in the company's future.
- Acquisition of shares through a stock plan grant indicates alignment of director's interests with shareholders.
- Participation in a dividend reinvestment plan suggests a long-term investment perspective.
Future Outlook
NA
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.
Related Party Transactions
- The indirect ownership by a Trust is a related party arrangement for beneficial ownership reporting, but the transactions themselves are acquisitions of company stock, not transactions with a related party in the typical sense of a business deal.
Stakeholder Impact
- Shareholders: Increased confidence due to director's increased stake, potentially signaling positive future performance.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 06/25/2025 | Date of stock acquisitions by William R. Shepard. |
| 06/26/2025 | Date the Form 4 was signed and filed. |
Recommendation
buyKeywords
CME Group Inc., CME, Form 4, Insider Trading, Stock Acquisition, Director Stock Plan, Dividend Reinvestment, Beneficial Ownership, William R. Shepard, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.